Over the past century, pharmaceutical product innovation changed the course of human disease. Device and technology innovation will shape the next century of medical care. With physician burnout and anemic labor productivity growth in health care delivery, technology proffers positive potential for disruptive innovation.

Automation, self-service, and interoperability can improve accessibility and affordability, with examples ranging from the recent approval of Tablo’s home hemodialysis machine to remote diagnosis of diabetic retinopathy.

Join AEI for a discussion on needed reforms in Food and Drug Administration (FDA) regulatory and clinical practice to unleash the power of artificial intelligence, automation, and software-driven medical devices. The panel features Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, and Jesse Ehrenfeld, president-elect of the American Medical Association.

Submit questions to jack.rowing@AEI.org or on Twitter with #AskAEIHealth

Subscribe to AEI's YouTube Channel
[ Ссылка ]

Like us on Facebook
[ Ссылка ]

Follow us on Twitter
[ Ссылка ]

For more information
[ Ссылка ]

AEI operates independently of any political party and does not take institutional positions on any issues. AEI scholars, fellows, and their guests frequently take positions on policy and other issues. When they do, they speak for themselves and not for AEI or its trustees or other scholars or employees.

More information on AEI research integrity can be found here: [ Ссылка ]

#aei #news #politics #government #education #livestream #live #healthcare #medical #pharma #fda #ama #panel #artificialintelligence

свернуть